doi:10.3969/j.issn.1671-2587.2021.01.033

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2021, Vol. 23 ›› Issue (1): 131-134.DOI: 10.3969/j.issn.1671-2587.2021.01.033

Received:2020-08-20 Published:2021-02-22

[1] TOMINAGA S.A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor[J].FEBS Lett,1989,258(2):301-304.
[2] WEINBERG E O,SHIMPO M,DE KEULENAER G W,et al.Expression and regulation of ST2,an interleukin-1 receptor family member,in cardiomyocytes and myocardial infarction[J].Circulation,2002,106(23):2961-2966.
[3] KRIECHBAUM S D,WIEDENROTH C B,PETERS K,et al.Galectin-3,GDF-15,and sST2 for the assessment of disease severity and therapy response in patients suffering from inoperable chronic thromboembolic pulmonary hypertension[J].Biomarkers,2020,25(7):578-586.
[4] VIANELLO E,DOZIO E,TACCHINI L,et al.ST2/IL-33 signaling in cardiac fibrosis[J].Int J Biochem Cell Biol,2019,116:105619.
[5] LIEW F Y,GIRARD J P,TURNQUIST H R.Interleukin-33 in health and disease[J].Nat Rev Immunol,2016,16(11):676-689.
[6] GABRYELSKA A,KUNA P,ANTCZAK A,et al.IL-33 mediated inflammation in chronic respiratory diseases-understanding the role of the member of IL-1 superfamily[J].Front Immunol,2019,10:692.
[7] MILLER A M,LIEW F Y.The IL-33/ST2 pathway-A new therapeutic target in cardiovascular disease[J].Pharmacol Ther,2011,131(2):179-186.
[8] ELSHERBINY N M,SAID E,ATEF H,et al.Renoprotective effect of calycosin in high fat diet-fed/STZ injected rats:Effect on IL-33/ST2 signaling,oxidative stress and fibrosis suppression[J].Chem Biol Interact,2020,315:108897.
[9] MAGER L F,RIETHER C,SCHÜRCH C M,et al.IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms[J].J Clin Invest,2015,125(7):2579-2591.
[10] WANG Y Q,LUO H M,WEI M Y,et al.IL-33/IL1RL1 axis regulates cell survival through the p38 MAPK pathway in acute myeloid leukemia[J].Leuk Res,2020,96:106409.
[11] ALEKSOVA A,PALDINO A,BELTRAMI A P,et al.Cardiac biomarkers in the emergency department:the role of soluble ST2 (sST2) in acute heart failure and acute coronary syndrome-there is meat on the bone[J].J Clin Med,2019,8(2):E270.
[12] DOLAPOGLU A,AVCI E,YILDIRIM T,et al.Using soluble ST2 to predict adverse postoperative outcomes in patients with impaired left ventricular function undergoing coronary bypass surgery[J].Medicina (Kaunas),2019,55(9):E572.
[13] AULA H,SKYTTÄ T,TUOHINEN S,et al.ST2 levels increased and were associated with changes in left ventricular systolic function during a three-year follow-up after adjuvant radiotherapy for breast cancer[J].Breast,2020,49:183-186.
[14] FUDIM M,KELLY J P,JONES A D,et al.Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure?[J].Am Heart J,2020,220:97-107.
[15] TYMIŃSKA A,KAPŁON-CIEŚLICKA A,OZIERAŃSKI K,et al.Association of galectin-3 and soluble ST2,and their changes,with echocardiographic parameters and development of heart failure after ST-segment elevation myocardial infarction[J].Dis Markers,2019,2019:9529053.
[16] 韩蕊,左霞,许丽明.血清可溶性ST2对老年急性心力衰竭患者病情程度及预后的评估价值[J].中华保健医学杂志,2019,21(5):470-472.
[17] 杨萍,刘培晶,丁澍,等.hs-cTnT、sST2联合BNP评估射血分数降低的慢性心力衰竭的临床意义[J].江苏大学学报(医学版),2019,29(5):414-418.
[18] CANER S,USLUOĞULLARI C A,BALKAN F,et al.Is IL-33 useful to detect early stage of renal failure?[J].Ren Fail,2014,36(1):78-80.
[19] BEREZIN A E.Cardiovascular biomarkers in routine screening of diabetic patients[J]. Clin Med Biochemistry Open Access, 2015, 1(107): 2471-2663.
[20] FOUSTERIS E,MELIDONIS A,PANOUTSOPOULOS G,et al.Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes,especially when accompanied with left ventricular diastolic dysfunction[J].Cardiovasc Diabetol,2011,10:101.
[21] BAO Y S,NA S P,ZHANG P,et al.Characterization of interleukin-33 and soluble ST2 in serum and their association with disease severity in patients with chronic kidney disease[J].J Clin Immunol,2012,32(3):587-594.
[22] ALAM M L,KATZ R,BELLOVICH K A,et al.Soluble ST2 and galectin-3 and progression of CKD[J].Kidney Int Rep,2019,4(1):103-111.
[23] HOMSAK E,EKART R.ST2 as a novel prognostic marker in end-stage renal disease patients on hemodiafiltration[J].Clin Chim Acta,2018,477:105-112.
[24] WANG S,WEI F,CHEN H Y,et al.The prognostic value of soluble ST2 in maintenance hemodialysis patients:a meta-analysis[J].Blood Purif,2020,49(1/2):114-120.
[25] GUNGOR O,UNAL H U,GUCLU A,et al.IL-33 and ST2 levels in chronic kidney disease:Associations with inflammation,vascular abnormalities,cardiovascular events,and survival[J].PLoS One,2017,12(6):e0178939.DOI:10.1371/journal.pone.0178939.
[26] NAKAJIMA S,ISHIMARU K,KOBAYASHI A,et al.Resveratrol inhibits IL-33-mediated mast cell activation by targeting the MK2/3-PI3K/Akt axis[J].Sci Rep,2019,9(1):18423.
[27] PENG Y Q,QIN Z L,FANG S B,et al.Effects of myeloid and plasmacytoid dendritic cells on ILC2s in patients with allergic rhinitis[J].J Allergy Clin Immunol,2020,145(3):855-867.e8.
[28] CAI H,WANG J,MO Y Q,et al.Salidroside suppresses group 2 innate lymphoid cell-mediated allergic airway inflammation by targeting IL-33/ST2 axis[J].Int Immunopharmacol,2020,81:106243.
[29] BAI F H,BA F Y,YOU Y J,et al.Decreased ST2 expression is associated with gastric cancer progression and pathogenesis[J].Oncol Lett,2019,17(6):5761-5767.
[30] EISSMANN M F,DIJKSTRA C,JARNICKI A,et al.IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization[J].Nat Commun,2019,10(1):2735.
[31] QI L,ZHANG Q Y,MIAO Y H,et al.Interleukin-33 activates and recruits natural killer cells to inhibit pulmonary metastatic cancer development[J].Int J Cancer,2020,146(5):1421-1434.
[32] LI A,HERBST R H,CANNER D,et al.IL-33 signaling alters regulatory T cell diversity in support of tumor development[J].Cell Rep,2019,29(10):2998-3008.e8.
[33] HATZIOANNOU A,BANOS A,SAKELAROPOULOS T,et al.An intrinsic role of IL-33 in Treg cell-mediated tumor immunoevasion[J].Nat Immunol,2020,21(1):75-85.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	LIN Shou, JIANG Wei-mei, ZHAN You-zhi, et al. Epidemiological Characteristics of Recent HIV-1 Infection in Blood Donors in Fuzhou Area [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 212-215.
[2]	ZHENG Jing-xian, LI Xiao-hui, SUN Hong-qiang. Clinical Observation of Children with Immune Thrombocytopenia and the Study of the Effect of ANA/ANAs in the Disease [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 231-235.
[3]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 561-564.
[4]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 565-567.
[5]	A Multi-center Study CHENG Jin-feng, JIAO Wei, ZHOU Hong-xia, et al. Application of Hepatitis B Virus,Hepatitis C Virus and Human Immunodeficiency Virus Nucleic Acid Detection in Patients Undergoing Surgery [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 568-573.
[6]	LI Hong-yan, TANG Shu-ming, LI Zhi-bo, et al. The Discrepancy between HCV Serological Test and Nucleic Acid Test in Preoperative and Pre-transfusion Patients [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 574-578.
[7]	XIE Hui, CAO Xiao-li, CHEN Yu-xin, et al. Analysis on the Drug Susceptibility,Carbapenem Resistance Determinants and Multi-locus Sequence Types of Carbapenem Resistant Escherichia coli [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 633-637.
[8]	ZHAO Hong-yan, LIU Geng-fu, HUANG Mao-wen, et al. Immunological Changes of Plasma in the Recovery Period of New Crown in Patients with Severe New Crown Pneumonia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 462-466.
[9]	ZHAO Feng-yong, GUO Zhong-hui, LI Qin, et al. Study on the Inactivation of Erythrocyte Blood Group Antigens by a 56 ℃ Water Bath [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 466-469.
[10]	SHEN Wei-wei, LI Zong-feng, PU Qiu-ning, et al. Changes and Significance of Serum Bilirubin Level in Patients with Lupus Nephritis [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 533-537.
[11]	LUO Sui-li, YANG Xiao-yong, ZHOU Jun, et al. Identification and Pedigree Analysis of A Case of cisAB Blood Group [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 545-548.
[12]	ZENG Fan-rong, LIU Jiang, YANG Guang, et al.. RT-PCR Analysis of Novel Coronavirus in Suspected Human Cases in Huainan [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(4): 371-375.
[13]	ZHAO Gang, GUO Fan, LI Jun, et al. Effect of Low-Efficiency Erythrocyte Antibodies in Tumor Patients with Blood Transfusion in Xinjiang [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(4): 383-386.
[14]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(4): 386-389.
[15]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(4): 397-399.